Medtimo

Medtimo Inc. is a newly formed subsidiary of Biorad Medisys LTD, offering an integrated portfolio of proven products and services that manage and treat obesity.

[Medtimo @MedtimoInc]

Medtimo Files Patent Infringement Complaint Against Allurion Technologies. As the cornerstone of our business, we have a long-standing commitment to developing and protecting our IP.

https://t.co/L9Zqk3NGgm

[Medtimo @MedtimoInc]

A new chapter begins! Today, Medtimo launches as a new subsidiary of @Bioradmed_India, signaling a transformative era for the company to meet the rising demand in both obesity treatment and stroke recovery.

Read the press release: https://t.co/SmnazSeV1p #Healthcare #MedTech

[Medtimo @MedtimoInc]

Vyome Announces Nasdaq Approval of Merger with ReShape Lifesciences, Set to Begin Trading as $HIND on Friday, August 15.

Read the press release: https://t.co/qR7VoUwjYe $RSLS

[Medtimo @MedtimoInc]

Vyome announces new board of directors and is expected to take control of ReShape's public entity this Friday, August 15. $RSLS will be renamed Vyome Holdings, Inc. post-closing and trade under the ticker symbol $HIND. Read the press release: https://t.co/W3ZWOjLlPC

[Medtimo @MedtimoInc]

The Lap-Band® Surgeon Summit begins today in Nashville.

ReShape Lifesciences® will host bariatric surgeons for sessions on Lap-Band® 2.0 FLEX, GLP-1s, and patient engagement strategies.

https://t.co/8NFyVL5kT0

$RSLS #LapBand #BariatricSurgeons #GLP1 #WeightLoss

[Medtimo @MedtimoInc]

ReShape’s inaugural Lap-Band® Surgeon Summit is taking place August 1-3, 2025, in Nashville, TN.

We are looking forward to bringing together leading bariatric surgeons, underscoring our continued commitment to growing the Lap-Band® franchise.

https://t.co/8NFyVL5kT0 $RSLS

[Medtimo @MedtimoInc]

ReShape Lifesciences® will host the inaugural LapBand Surgeon Summit Aug 1–3 in Nashville, TN.

The event will unite bariatric surgeons to support clinical collaboration around the Lap-Band® Program.

Read more via @ctrialvanguard: https://t.co/2pC6c5p5XE

$RSLS #LapBand

[Medtimo @MedtimoInc]

ReShape Lifesciences® to host inaugural Lap-Band® Surgeon Summit, August 1-3, 2025, in Nashville, TN.

Read the press release: https://t.co/iTgcE0qBxh

$RSLS #LapBand #WeightLoss #BariatricSurgeons

[Medtimo @MedtimoInc]

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025.

Read the press release: https://t.co/ifOSIr1Pbz $RSLS

[Medtimo @MedtimoInc]

ReShape granted US Patent 12,350,179, entitled Intragastric Device Patent covers claims for an #intragastricballoon a swallowable capsule with self-sealing fill valve and degradable release valve The patent will provide protection into January 2031 Details https://t.co/eXd5msJU5o

[Medtimo @MedtimoInc]

Type 2 diabetes remains a global health challenge despite numerous interventions. "Our Diabetes Neuromodulation system offers a novel approach by using targeted bioelectronic modulation," said Dr. Jonathan Waataja. Read more https://t.co/I4yp77dqpn #Type2Diabetes #Neuromodulation

[Medtimo @MedtimoInc]

ReShape Lifesciences® granted US patent related to an intragastric balloon system.

The patent covers a swallowable capsule with a self-sealing fill valve and a degradable release valve

Read press release
https://t.co/aPa0ymoxln
$RSLS #MedTech #Healthcare #IntragastricBalloon

[Medtimo @MedtimoInc]

"The granting of this Australian patent is a major milestone that strengthens our international IP position," said CEO Paul F. Hickey. Patent protection until 2039. Read more: https://t.co/I4yp77dqpn #Healthcare #Type2Diabetes

[Medtimo @MedtimoInc]

ReShape Lifesciences® announces strategic cost reductions and provides an update on the merger agreement with Vyome Therapeutics and asset purchase agreement with Biorad Medisys.

Read the press release: https://t.co/9hwsQaroEd

[Medtimo @MedtimoInc]

ReShape Lifesciences® is pleased to announce that it has been granted a key international patent in Australia for its proprietary diabetes #neuromodulation technology.

Read the press release: https://t.co/timq7EUc05

$RSLS #Healthcare #MedTech

[Medtimo @MedtimoInc]

ReShape is proud to partner with Recon Supply to deliver STIMEL-03 and Lap-Band® 2.0 FLEX across VA and DoD #healthcare systems.

Together, these technologies reflect our commitment to delivering high-impact, clinically proven solutions.
https://t.co/3m8xkCAf9w $RSLS

[Medtimo @MedtimoInc]

ReShape Lifesciences® Signs Exclusive Distribution Agreement with Recon Supply to Access the VA and DoD Markets.

Read more: https://t.co/3m8xkCAf9w

$RSLS #Healthcare #MedTech #VeteransAdministration

[Medtimo @MedtimoInc]

This week, Reshape announced EU MRR and UKCA certification for its full European and UK product portfolio, well ahead of the 2027 deadline.

ICYMI, read the announcement: https://t.co/g6E9GNr2TI #Medtech #Healthcare

[Medtimo @MedtimoInc]

ReShape Lifesciences® Announces EU MDR Certification for Entire European and United Kingdom Product Portfolio.

Read the press release:
https://t.co/vJ1BmvLLgP $RSLS #MedTech #Healthcare

[Medtimo @MedtimoInc]

Today, we pause to remember the brave men and women who made the ultimate sacrifice for our country. We are eternally grateful for their service and sacrifice, and we honor their legacy.